Takeda Recognized as One of the Global 100 Most Sustainable Corporations for Second Consecutive Year
Takeda Pharmaceutical Company Limited [TOKYO:4502] , (“Takeda”) is proud to be named by Corporate Knights to the 2017 Global 100 Most Sustainable Corporations in the World Index . Takeda achieved this distinction for the second consecutive year and it is based on 14 key performance indicators, including energy productivity, innovation capacity, safety performance and leadership diversity.
Since 1781, Takeda has been committed to improving the future of healthcare. Inclusion in the Global 100 Index highlights the progress Takeda has made in its corporate responsibility efforts and sustainability planning.
“Takeda is honored to be included among such distinguished global corporations again,” said Haruhiko Hirate, Corporate Communications & Public Affairs Officer. “For Takeda, corporate social responsibility (CSR) is rooted in putting the patient at the center of everything we do. While we continuously strive to improve our business processes, we are also proud to engage in activities that promote a sustainable society and reflect our commitment to being a good corporate citizen.”
In conducting its activities, Takeda adheres to internationally recognized guidelines, such as the United Nations Global Compact’s 10 principles, and long-term international targets, such as the Sustainable Development Goals (SDGs).
About Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit http://www.takeda.com/news .
Additional information about Takeda is available through its CSR Data Book 2016, http://www.takeda.com/csr/reports/ .
Takeda Pharmaceutical Company Limited
Tsuyoshi Tada, +81-3-3278-2417
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
AZ-VERSUM-MATERIALS19.4.2018 22:17 | pressemeddelelse
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA
PHARNEXT19.4.2018 17:47 | pressemeddelelse
Pharnext to Showcase PLEOTHERAPY™ R&D Platform at the 8th Annual Global Orphan Drug Conference
CA-MASIMO19.4.2018 17:03 | pressemeddelelse
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices
CA-SYNTERACT19.4.2018 16:08 | pressemeddelelse
Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform
NEL-ASA19.4.2018 16:02 | pressemeddelelse
Nel ASA: Receives Additional Purchase Order from Nikola
VOITH19.4.2018 15:41 | pressemeddelelse
Voith and Franka Emika Form a Strategic Partnership
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum